@next.health

Next Health operates regenerative medicine and wellness centers specializing in peptide therapy treatments across multiple locations. The company administers targeted amino acid compounds including Sermorelin, Ipamorelin, BPC-157, CJC-1295, and Thymosin Alpha-1 under medical supervision. Co-founder and CEO Darshan Shah leads the organization's development of cellular regeneration and metabolic optimization protocols. The clinical practice focuses on three core treatment areas: anti-aging and longevity, performance optimization, and recovery support. Treatment plans incorporate peptide formulations designed to influence hormone balance, immune function, and tissue repair. Medical staff customize protocols based on individual biomarkers and health objectives. Next Health produces educational content explaining peptide therapy applications in inflammation reduction, gut health improvement, and metabolic enhancement. The company maintains partnerships with healthcare providers and wellness practitioners seeking regenerative medicine resources. Their clinical model combines direct patient care with professional education in evidence-based peptide protocols.